M A Shibata Selected Research

Biological Factors

2/2000

The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M A Shibata Research Topics

Disease

5	Neoplasms (Cancer) 04/2011 - 02/2000
5	Breast Neoplasms (Breast Cancer) 04/2011 - 02/2000
5	Carcinoma (Carcinomatosis) 04/2011 - 02/2000
2	Prostatic Neoplasms (Prostate Cancer) 10/2001 - 02/2000
1	Adenocarcinoma 04/2011
1	Noninfiltrating Intraductal Carcinoma (DCIS) 10/2001
1	Carcinogenesis 12/2000

Drug/Important Bio-Agent (IBA)

5	Tumor Viral Antigens (Large T Antigen)IBA 04/2011 - 02/2000
3	SteroidsIBA 04/2011 - 02/2000
3	Hormones (Hormone)IBA 04/2011 - 02/2000
2	Carrier Proteins (Binding Protein)IBA 04/2011 - 02/2000
2	Estrogens (Estrogen)FDA Link 10/2001 - 12/2000
2	Estrogen Receptor alphaIBA 12/2000 - 02/2000
1	K-18 conjugate (K18)IBA 04/2011
1	Phenobarbital (Luminal)FDA Link 04/2011
1	Estrogen ReceptorsIBA 04/2011
1	Progesterone Receptors (Progesterone Receptor)IBA 04/2011
1	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 10/2001
1	Alitretinoin FDA Link 10/2001
1	AndrogensIBA 10/2001
1	Dehydroepiandrosterone (DHEA)IBA 10/2001
1	Estradiol (Delestrogen)FDA LinkGeneric 10/2001
1	Selenomethionine (Sethotope)FDA Link 10/2001
1	alpha-Tocopherol FDA Link 10/2001
1	CyclinsIBA 01/2001
1	Estrogen Receptor betaIBA 12/2000
1	CytokinesIBA 02/2000
1	Biological FactorsIBA 02/2000

Therapy/Procedure

2	Therapeutics 01/2001 - 02/2000
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 12/2000
1	Ovariectomy (Oophorectomy) 12/2000